← Eichor
Study identifier: NCT06556446 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Condition: Ischemic Stroke  ·  Sponsor: Insel Gruppe AG, University Hospital Bern

PhaseN/A
Planned participants2800
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

DO-IT is an international, prospective observational registry evaluating whether the administration of intravenous thrombolysis (IVT) is safe and improves functional outcome in ischemic stroke patients with recent direct oral anticoagulant (DOAC) intake. For this purpose, information on 2800 adult participants experiencing an acute ischemic stroke will be obtained at several high-volume international stroke centers and divided into three groups: IVT with recent DOACs intake (DOAC+IVT), and recent DOAC intake not receiving IVT (DOAC) as well as anonymized patients without DOAC receiving IVT. The patients are followed up for 90 days after the index event. treatment recommendations from the described observations. The investigators hypothesize that also more liberal decisions for IVT in patients with recent DOAC intake are not associated with an increased risk for symptomatic intracerebral hemorrhage (sICH) and result in better functional outcome at 3 month.

This description comes directly from the study's public registry record.

Talk to the study team

Thomas Meinel, MD, PhD  ·  +41 31 66 4 25 67  ·  thomas.meinel@insel.ch

Freschta Zipser-Mohammadzada, PhD  ·  +41 31 63 2 60 83  ·  nctu@insel.ch

Always discuss trial participation with your own doctor first.

Locations (33)

Medical University of InnsbruckInnsbruck, AustriaNot Yet Recruiting
Cliniques Universitaires Saint LucBrussels, BelgiumNot Yet Recruiting
UZ LeuvenLeuven, BelgiumNot Yet Recruiting
The University of British Columbia | Vancouver General HospitalVancouver, CanadaNot Yet Recruiting
CHU CaenCaen, FranceNot Yet Recruiting
Nordwest-Krankenhaus SanderbuschSanderbusch, GermanyNot Yet Recruiting
Universitäsklinikum TübingenTübingen, GermanyNot Yet Recruiting
Dept. of Medicine, University of ThessalyLarissa, Thessaly, GreeceRecruiting
A.O.R.N. Antonio Cardarelli HospitalNaples, ItalyNot Yet Recruiting
Ospedali Riuniti HospitalPalermo, ItalyNot Yet Recruiting
Ospedale "Bufalini", CesenaPerugia, ItalyRecruiting
AUSL-IRCCS di Reggio EmiliaReggio Emilia, ItalyNot Yet Recruiting

+ 21 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06556446